Stocks | |||||
The table gives an overview of all stocks, alphabetically sorted. | |||||
A B C D E F G H I J K L M N O P Q R S T U V W X Y Z |
Name | Symbol | Analysis date | Close | +/- % |
T Stamp A | IDAI | Sep 19, 2024 | 0.23 | -1.47 |
T-Mobile US | TMUS | Sep 19, 2024 | 199.64 | +1.51 |
T. Rowe Price Blue Chip Growth ETF | TCHP | Sep 19, 2024 | 39.46 | +2.36 |
T. Rowe Price Dividend Growth ETF | TDVG | Sep 19, 2024 | 40.88 | +1.16 |
T. Rowe Price Equity Income ETF | TEQI | Sep 19, 2024 | 41.71 | +0.94 |
T. Rowe Price Group | TROW | Sep 19, 2024 | 110.55 | +2.24 |
T. Rowe Price Growth Stock ETF | TGRW | Sep 19, 2024 | 37.54 | +2.27 |
T2 Biosystems | TTOO | Sep 19, 2024 | 2.20 | +2.33 |
Taboola.com | TBLA | Sep 19, 2024 | 3.26 | +2.19 |
Tactile Systems Technology | TCMD | Sep 19, 2024 | 14.24 | +3.41 |
Taitron Components A | TAIT | Sep 19, 2024 | 2.87 | +2.14 |
Taiwan Fund | TWN | Sep 19, 2024 | 44.55 | +3.56 |
Taiwan Index MSCI Ishares | EWT | Sep 19, 2024 | 53.71 | +3.25 |
Taiwan Semiconductor Manufacturing ADR | TSM | Sep 19, 2024 | 176.22 | +5.34 |
Take-Two Interactive Software | TTWO | Sep 19, 2024 | 153.66 | +0.22 |
Takeda Pharmaceutical ADR | TAK | Sep 19, 2024 | 14.93 | +0.74 |
TAL Education Group ADR | TAL | Sep 19, 2024 | 8.18 | +8.20 |
Talen Energy | TLN | Sep 19, 2024 | 175.36 | 0.00 |
Talis Biomedical | TLIS | Sep 19, 2024 | 4.38 | 0.00 |
Talkspace | TALK | Sep 19, 2024 | 2.10 | +2.94 |
Talos Energy | TALO | Sep 19, 2024 | 11.51 | +1.59 |
Talphera | TLPH | Sep 19, 2024 | 0.94 | +4.60 |
Tamboran Resources | TBN | Sep 19, 2024 | 20.19 | 0.00 |
Tandem Diabetes Care | TNDM | Sep 19, 2024 | 44.45 | +4.24 |
Tanger | SKT | Sep 19, 2024 | 31.95 | +2.08 |
Tango Therapeutics | TNGX | Sep 19, 2024 | 8.41 | +1.57 |
Tantech | TANH | Sep 19, 2024 | 0.16 | -1.39 |
Taoping | TAOP | Sep 19, 2024 | 0.57 | -2.67 |
Tapestry | TPR | Sep 19, 2024 | 42.82 | -0.72 |
Targa Resources | TRGP | Sep 19, 2024 | 152.21 | +0.01 |
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.
Investtech guarantees neither the entirety nor accuracy of the analyses. Any consequent exposure related to the advice / signals which emerge in the analyses is completely and entirely at the investors own expense and risk. Investtech is not responsible for any loss, either directly or indirectly, which arises as a result of the use of Investtechs analyses. Details of any arising conflicts of interest will always appear in the investment recommendations. Further information about Investtechs analyses can be found here disclaimer.
The content provided by Investtech.com is NOT SEC or FSA regulated and is therefore not intended for US or UK consumers.